Mao, C., Fang, J., Zou, S., Huang, Y., Chen, X., Ding, X., . . . Ma, Z. (2024). Discovery of the First-in-Class Dual-Target ROCK/HDAC Inhibitor with Potent Antitumor Efficacy in Vivo That Trigger Antitumor Immunity. Journal of medicinal chemistry.
Chicago-Zitierstil (17. Ausg.)Mao, Churu, et al. Discovery of the First-in-Class Dual-Target ROCK/HDAC Inhibitor with Potent Antitumor Efficacy in Vivo That Trigger Antitumor Immunity. Journal of medicinal chemistry, 2024.
MLA-Zitierstil (9. Ausg.)Mao, Churu, et al. Discovery of the First-in-Class Dual-Target ROCK/HDAC Inhibitor with Potent Antitumor Efficacy in Vivo That Trigger Antitumor Immunity. Journal of medicinal chemistry, 2024.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.